IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI picks who gets immunotherapy after liver cancer surgery
Disease control Not yet recruitingThis study tests whether a computer model can help decide which liver cancer patients should receive immunotherapy (PD-1 inhibitors) after surgery to prevent the cancer from coming back. About 300 adults who had their liver cancer completely removed will be enrolled. The goal is …
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Mushroom-Derived pill plus radiation shows promise against tough cancers
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced solid tumors that have not responded to standard therapies. Participants will take PRaG-1 tablets (made from a natural fungus), receive targeted radiation, immune-boosting injections, and immunotherapy drugs. T…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Pain pills vs. cancer treatment: new study investigates opioid impact on immunotherapy
Knowledge-focused Not yet recruitingThis study looks at how opioid painkillers influence the effectiveness of immunotherapy in people with advanced lung cancer and moderate to severe pain. Researchers will track 100 participants to see if better pain control leads to better cancer outcomes. The goal is to understan…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Hubei Cancer Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC